Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel mutation in KIF23 causing congenital dyserythropoietic anemia type III in patients who underwent allogeneic hematopoietic stem cell transplantation.
Fujikawa T, Uemura S, Hasegawa D, Morisada N, Nakamura S, Kozaki A, Saito A, Kishimoto K, Ishida T, Mori T, Yakushijin K, Katayama Y, Yamashita D, Wakamatsu M, Hamada M, Muramatsu H, Takahashi Y, Kosaka Y. Fujikawa T, et al. Among authors: kozaki a. Pediatr Blood Cancer. 2024 Jun;71(6):e30736. doi: 10.1002/pbc.30736. Epub 2024 Mar 24. Pediatr Blood Cancer. 2024. PMID: 38523246 No abstract available.
Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells.
Hartomo TB, Kozaki A, Hasegawa D, Van Huyen Pham T, Yamamoto N, Saitoh A, Ishida T, Kawasaki K, Kosaka Y, Ohashi H, Yamamoto T, Morikawa S, Hirase S, Kubokawa I, Mori T, Yanai T, Hayakawa A, Takeshima Y, Iijima K, Matsuo M, Nishio H, Nishimura N. Hartomo TB, et al. Among authors: kozaki a. Oncol Rep. 2013 Apr;29(4):1629-36. doi: 10.3892/or.2013.2286. Epub 2013 Feb 12. Oncol Rep. 2013. PMID: 23417100
Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia.
Hirase S, Hasegawa D, Takahashi H, Moriwaki K, Saito A, Kozaki A, Ishida T, Yanai T, Kawasaki K, Yamamoto N, Kubokawa I, Mori T, Hayakawa A, Nishimura N, Nishio H, Iijima K, Kosaka Y. Hirase S, et al. Among authors: kozaki a. Int J Hematol. 2015 Nov;102(5):594-601. doi: 10.1007/s12185-015-1875-0. Epub 2015 Oct 6. Int J Hematol. 2015. PMID: 26440971 Clinical Trial.
Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients.
Yamamoto N, Kozaki A, Hartomo TB, Yanai T, Hasegawa D, Kawasaki K, Kosaka Y, Matsuo M, Hirase S, Mori T, Hayakawa A, Iijima K, Nishio H, Nishimura N. Yamamoto N, et al. Among authors: kozaki a. Oncol Lett. 2015 Nov;10(5):3228-3232. doi: 10.3892/ol.2015.3710. Epub 2015 Sep 16. Oncol Lett. 2015. PMID: 26722317 Free PMC article.
[Successful non-myeloablative allogenic bone marrow transplantation in a child with severe congenital neutropenia complicated by chronic pulmonary infection].
Nino N, Kozaki A, Hasegawa D, Ueda G, Takahashi H, Miyata K, Ochi S, Yamashita T, Takafuji S, Uemura S, Yokoi T, Saito A, Ishida T, Kawasaki K, Nakamura K, Kobayashi M, Kosaka Y. Nino N, et al. Among authors: kozaki a. Rinsho Ketsueki. 2016 Jun;57(6):742-7. doi: 10.11406/rinketsu.57.742. Rinsho Ketsueki. 2016. PMID: 27384854 Japanese.
Early detection of tumor relapse/regrowth by consecutive minimal residual disease monitoring in high-risk neuroblastoma patients.
Hirase S, Saitoh A, Hartomo TB, Kozaki A, Yanai T, Hasegawa D, Kawasaki K, Kosaka Y, Matsuo M, Yamamoto N, Mori T, Hayakawa A, Iijima K, Nishio H, Nishimura N. Hirase S, et al. Among authors: kozaki a. Oncol Lett. 2016 Aug;12(2):1119-1123. doi: 10.3892/ol.2016.4682. Epub 2016 Jun 7. Oncol Lett. 2016. PMID: 27446404 Free PMC article.
Successful Treatment of Transplantation-associated Atypical Hemolytic Uremic Syndrome With Eculizumab.
Hasegawa D, Saito A, Nino N, Uemura S, Takafuji S, Yokoi T, Kozaki A, Ishida T, Kawasaki K, Yasumi T, Sakata N, Ohtsuka Y, Hirase S, Mori T, Nishimura N, Kusumoto M, Ogawa Y, Tominaga K, Nakagawa T, Kanda K, Tanaka R, Kosaka Y. Hasegawa D, et al. Among authors: kozaki a. J Pediatr Hematol Oncol. 2018 Jan;40(1):e41-e44. doi: 10.1097/MPH.0000000000000862. J Pediatr Hematol Oncol. 2018. PMID: 28538511
84 results